SCM
FBIO icon

Suffolk Capital Management’s Fortress Biotech FBIO Stock Holding History

Suffolk Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-24,907
Closed -$3.21M – 144
2013
Q2 		$3.21M Buy
+24,907
New +$3.67M 0.46% 68

Other funds holding FBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Suffolk Capital Management's FBIO Position: Q3 2013 in Review

Suffolk Capital Management sold out of Fortress Biotech (FBIO) in Q3 2013, closing a stake of 24,907 shares — an estimated $3.21M sold.

Suffolk Capital Management first reported a position in FBIO in Q2 2013 and held it in 1 quarter. The position peaked at $3.21M in Q2 2013. 81 funds tracked by Wall St. Rank hold FBIO as of Q3 2013.

  • Suffolk Capital Management reported no remaining Fortress Biotech position as of Q3 2013 after selling out during the quarter.
  • Suffolk Capital Management sold 24,907 Fortress Biotech shares in Q3 2013, an estimated $3.21M.
  • Suffolk Capital Management first reported a position in Fortress Biotech in Q2 2013 and held it in 1 quarter.
  • Suffolk Capital Management's Fortress Biotech position peaked at $3.21M in Q2 2013.
  • 81 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2013.

Based on Suffolk Capital Management's 13F filing for Q3 2013, filed 7 Nov 2013.